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When neurons are overstimulated, the brain experiences ischemic trauma, which causes 
cell damage and eventually death: a phenomenon called excitotoxicity. But, not all regions of the 
brain are equally affected. The suprachiasmatic nucleus (SCN)—which houses the body’s 
twenty-four-hour clock that regulates circadian rhythms—might be more resistant to excitotoxic 
shock than other brain regions. However, a systematic analysis of the degree of damage to the 
SCN compared to the hippocampus and cortex following an excitotoxic stimulus has not yet 
been explored. To investigate this phenomenon, tissues were isolated from different areas of the 
mouse brain including the SCN, hippocampus, and cortex and treated with NMDA to induce 
excitotoxicity. Then the slices were fixed and sectioned, and the relative amount of cell death 
was quantified using propidium iodide (PI), a cell death marker. The data show there is 
significantly less cell death in the SCN relative to the other tissues, indicating that the SCN 
might be intrinsically more resilient to ischemia-associated excitotoxicity compared to other 
brain regions. This lesser cell damage or death characteristic of the SCN, represented as lesser 
percentages of Grade 2 and Grade 3 cells compared to the total number of cells both before and 
after NMDA treatment (an excitotoxic stimulus), is sustained across all time points (Zeitgeber 
time (ZT) 6, ZT 12, ZT 16, ZT 22) with no apparent circadian rhythm, despite the SCN 
containing the primary circadian clock and exhibiting daily changes in cell signaling and 
morphology. Future investigation involves understanding the mechanisms underlying SCN 
excitotoxic resiliency, with a specific focus on relative damage/death across different cell types 
and the involvement of microglia in excitotoxic responses in the SCN, anterior hypothalamus 
(AH), hippocampus, and cortex. We would also like to add more replicates to each experiment to 




relationships between the SCN and other brain regions. We hope that these findings can lead to 
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In the United States, ischemic stroke is the primary cause of adult disability and fourth 
leading cause of death. In less developed nations, stroke incidence and mortality are 
continuously rising. Its main effects are termed the “Dreaded-D’s,” which include chronic 
disability, dementia, and death. Since the first two of these burdening consnequences often do 
not cause death until many years later, there is an extremely high prevalence (3% or 
approximately 7 million people) of stroke in developed nations such as the United States, where 
hospitals are better equipped to better control vascular risk factors and prevent death in these 
patients [11]. Due to the severity of its consequences and prominence in both undeveloped and 
industrial nations, it is important to understand the cellular mechanisms underlying stroke that 
induce cell damage and death as well as how those mechanisms differ across various brain 
regions such as the SCN, AH, hippocampus, and cortex. 
Glutamate, the main excitatory neurotransmitter in the brain, primarily acts through 
binding to -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-
aspartate (NMDA) receptors on neurons and glial cells in the brain to facilitate vital functions 
such as learning, memory, and behavior [6]. However, in an ischemic event such as a stroke, 
cerebral blood flow decreases significantly, inducing failure of neuronal Na+/K+ pumps and thus 
excessive glutamate release and NMDA receptor overactivation. This results in a rapid influx of 
calcium ions into postsynaptic neurons, activation of nitric oxide synthase, and production of 
nitric oxide that is eventually converted into toxic free radicals. These cellular events subsequent 
to the initial impaired blood flow generate cell damage and death, termed excitotoxicity, which 
spreads from the core ischemic zone to its periphery [2]. In the event of an ischemic stroke, 





left side of the brain, the right side of the body may exhibit symptoms including, but not limited 
to right-side paralysis, Broca’s or Wernicke’s aphasia, cautious behavior, and memory loss. If in 
the right side of the brain, the left side of the body may exhibit symptoms including, but not 
limited to left-side paralysis, impaired vision, inquisitive behavior, and memory loss [1]. 
NMDA is an amino acid derivative of glutamate that mimics its excitotoxic effects by 
activating NMDA receptors and depolarizing neurons. When glutamate or NMDA binds to the 
highly calcium-permeable NMDA receptor, it can remain bound and activate it for hundreds of 
milliseconds, which allows for a rapid influx of Ca2+ ions [12]. If the excitatory signaling from 
glutamate release is enough to result in a postsynaptic membrane depolarization that causes the 
neuron to reach threshold, an action potential occurs. Unlike during normal brain function, 
excess NMDA receptor stimulation is deleterious to the brain. Previous studies have found that 
NMDA-induced lesions to the rat hippocampus—the brain region implicated in learning and 
memory—result in more errors and increased latency in reaching learning criterion in tasks 
assessing both reference and working memory in a W-track continuous spatial alternation task 
[8]. Similarly, a high extracellular concentration of NMDA induces excitotoxicity in mixed 
cortical cultures including both neurons and glial cells through interactions with somatic 
receptors at the synapse [15]. However, while previous works show that excess NMDA receptor 
activation induces significant hippocampal and cortical degeneration, a systematic investigation 
of NMDA-induced excitotoxicity across different brain regions has not been done [3]. 
There are two standard treatments for ischemic stroke: tissue plasminogen activator (tPA) 
and endovascular therapy. The first involves intravenous administration of tPA to restore blood 
flow by dissolving the clot that caused the stroke; however, it can result in further complications 





must be given within 3 hours of stroke onset for the greatest benefit, though a patient’s 
likelihood of survival and ability to remain independent is increased significantly as long as it is 
within 6 hours [14]. During an emergency endovascular procedure, physicians either deliver tPA 
directly to where the stroke is occurring through a catheter inserted into the femoral artery (intra-
arterial thrombolysis) or remove the clot by inserting a stent retriever into the blocked blood 
vessel in the brain to trap and remove the clot, which is typically used for patients with large 
clots that cannot be completely dissolved with tPA and performed together with intravenous tPA 
treatment [17]. 
The purpose of this study was to compare excitotoxic responses in the SCN compared to 
the AH, hippocampus, and cortex, which would enable us to determine whether the SCN exhibits 
endogenous resilience to excitotoxic stimuli based on dosage and circadian time. We used 
NMDA to trigger neuronal overstimulation in brain slices containing the hippocampus, cortex, 
AH, and SCN and measured the degree of damage among the cells within each region. Then, we 
compared the percent of damaged or dead cells across the brain regions. As this is an ongoing 
investigation, we also hope to compare the effects of AMPA receptor activation across each of 
the aforementioned brain regions to determine whether there are more cellular processes through 
which excessive calcium influx induces neuronal excitotoxicity. Additionally, we would like to 
use different techniques for quantifying cell death intensity such as lactate dehydrogenase (LDH) 
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays to observe 
degree of damage through level of mitochondrial breakdown rather than nuclear envelope 
breakdown. Lastly, we want to explore whether SCN microglia differ from those in other regions 
in baseline of excitotoxicity-induced morphology. A more in depth understanding of the 





more successful ischemic stroke treatments. By allowing medical and health care professionals 
to mimic this specific cellular defense mechanism in other brain regions, they can potentially 
reduce or eliminate the deleterious effects of ischemic stroke in various parts of the brain and 
ensure a quicker, stronger, and overall more successful recovery. 
2. Materials and Methods 
2.1 Animals 
All experiments used C57BL/6 wildtype (WT) mice from Engivo. All mice were housed 
in polycarbonate cages in the University of Tennessee, Knoxville animal facility in a 12h- 
light/12h-dark cycle (12L:12D) and fed and provided water ad libitum in a temperature-
controlled room (23C). Adult male mice aged 3-4 months old at the beginning of each 
experiment were used to obtain coronal cortex, hippocampus, and SCN/AH-containing brain 
slices. These experiments followed guidelines approved by the University of Tennessee, 
Knoxville Institutional Animal Care and Use Committee. 
2.2 Brain slice and experimental preparation 
2.2.1 Dose-Response experiments: Brain slices were made between ZT 0 and ZT 1.5 and 
maintained using standard protocols of the laboratory in Earle’s Balanced Salt Solution (EBSS) 
medium until the time of drug treatment. At ZT 6 perfusion was stopped, and the medium in the 
tissue chamber was replaced with EBSS alone or EBSS containing either 50M, 100M, or 
500M NMDA. After 1 hour the medium was replaced with normal EBSS and perfusion was 
reinstated. 
2.2.2 Time Dependence experiments: Brain slices were made between ZT 0 - ZT 1.5 (for 





and maintained using standard protocols. Slices were treated with EBSS alone or EBSS 
containing 50M NMDA for 1 hour at ZT 6, ZT 12, ZT 16, and ZT 22 using the procedure 
described above. 
2.3 Drug treatments 
After a drug or control treatment, slices were maintained in normal EBSS for an 
additional 3 hours. Slices were then perfused with EBSS containing 4.6g/L PI for an 
additional 2 hours. Slices were then removed from the slice chamber and placed in cold 4% 
paraformaldehyde (PFA) for 10 minutes followed by 30% sucrose overnight. Tissue samples 
were then embedded in optimal cutting temperature (OCT) compound and frozen at -80C until 
sectioning. Slices were sectioned using a cryostat (10 thick) and cover slipped with DAPI-
infused mounting media (VECTASHIELD). 
2.4 Data analysis 
All data analysis was conducted by individuals blind to the experimental conditions using 
ImageJ Analysis software. Images were split into the 4’,6-diamidino-2-phenylindole (DAPI) 
channel, showing the total number of cells, and the PI channel, which only shows damaged cells. 
In the PI channel, fluorescence varies in intensity based on the degree of cell damage or death 
[10]. Specified regions of interest (ROIs) were drawn based on DAPI staining. The total number 
of cells were marked and counted using the DAPI channel only. Then, the marked cells were 
overlaid onto the PI channel, and the PI intensity was calculated for each cell. PI intensity 
thresholds were determined independently by 5 individuals, which separated cells into three 
categories: faint/diffuse PI intensity indicating minimal or no damage (Grade 0-1), moderate/less 





indicating dead/extremely damaged cells (Grade 3). See Figure 1 for example histology and 
ROIs. 
2.5 Statistical analysis 
Typically, an analysis of variance (ANOVA) test would be used in this study given the 
many different comparisons across experimental groups; however, there are not enough samples 
within each group to conduct this type of analysis. Therefore, to obtain an initial assessment of 
statistical significance of preliminary results, a series of student t-tests were conducted with the 
level of significance set at p < 0.05. 
3. Results 
3.1 The SCN exhibits the least amount of cell death 
Fluorescent microscopy of control and NMDA-treated sections for all 4 brain regions 
reveal PI (red) relative to DAPI (blue) staining levels (Figure 1). The results of regional 
comparison experiments are displayed in Figures 2-5, showing that 50M NMDA-bath 
applications ZT 6 (Figure 2), ZT 12 (Figure 3), ZT 16 (Figure 4), and ZT 22 (Figure 5) to brain 
slices generally induced a higher percentage of Grade 2 and Grade 3 cells across all regions 
compared to the SCN, although the AH was only different at ZT 22. However, more replicates 
are needed to confirm this relationship. These data confirm and extend previous studies showing 







Fig. 1. Less cell death in the SCN compared to the AH, cortex, and hippocampus CA1 and CA3 regions (n = 3-4). 
Total number of cells is indicated by blue DAPI staining, which does not change based on degree of damage to the 
cell. Number of dead cells is indicated by the red PI staining, which varies in intensity based on degree of damage to 
the cell. 
 
Fig. 2. Less cell death in the SCN at ZT 6 (n = 3) compared to the cortex and hippocampus dentate gyrus (DG), 
CA1, and CA3 regions. Data were analyzed using a student’s t-test, where a * symbol indicates a statistically 


















Fig. 3. Less cell death in the SCN at ZT 12 (n = 3) compared to the cortex, and hippocampus CA3 region. Data were 
analyzed using a student’s t-test, with a * symbol indicating statistical significance at p < 0.05. 
 
Fig. 4. Less cell death in the SCN at ZT 16 (n = 3-4) compared to the cortex. Data were analyzed using a student’s t-
test, with a * symbol indicating statistical significance at p < 0.05. 
 
Fig. 5. Less cell death in the SCN at ZT 22 (n = 3) compared to the AH, cortex, and hippocampus CA1 and CA3 








3.2 Cell death in all brain regions does not exhibit circadian rhythms 
The SCN is the locus of the primary mammalian circadian clock. As such, it is known 
that the molecular environment of the SCN regarding gene and cell-surface receptor expression 
changes based on circadian rhythms, including ion channels and their functions, transcription 
factor response elements, and CREB phosphorylation regulation [7, 9, 16]. Likewise, other brain 
regions exhibit a variety of circadian rhythms in cell activitiy due to inpyt from the SCN. 
Because of this, we investigated whether the resistance/susceptibility to excitotoxic damage 
varies with circadian time. We found that degree of cell damage resulting from in vitro NMDA 
treatment does not change based on the time of treatment administration in any of these regions. 
As seen in Figures 6-11, NMDA treatments at ZT 6, ZT 12, ZT 16, and ZT 22 resulted in 
roughly the same amounts of cell death, as evidenced by similar percentage values for Grade 1, 
Grade 2, and Grade 3 cells in each brain region. 
 
Fig. 6. Constant percentage of cell death relative to total number of cells in the SCN at ZT 6, ZT 12, ZT 16, and ZT 






Fig. 7. Differences in percentage of cell death relative to total number of cells in the AH across ZT 6, ZT 12, ZT 16, 
and ZT 22 between control and 50M NMDA-treated slices, with the least amount of NMDA-induced cell death 
occurring at ZT 6 and ZT 12 (n = 3-5). 
 
Fig. 8. Differences in percentage of cell death relative to total number of cells in the cortex across ZT 6, ZT 12, ZT 
16, and ZT 22 between control and 50M NMDA-treated slices, with the most amount of NMDA-induced cell death 

























































































































































Fig. 9. Differences in percentage of cell death relative to total number of cells in the hippocampus CA1 region 
across ZT 6, ZT 12, ZT 16, and ZT 22 between control and 50M NMDA-treated slices, with the most amount of 
NMDA-induced cell death occurring at ZT 6 and ZT 22 (n = 3). 
 
Fig. 10. Differences in percentage of cell death relative to total number of cells in the hippocampus CA3 region 
across ZT 6, ZT 12, ZT 16, and ZT 22 between control and 50M NMDA-treated slices, with the least amount of 
NMDA-induced cell death occurring at ZT 12 (n = 3). 
 
Fig. 11. Differences in percentage of cell death relative to total number of cells in the hippocampus DG across ZT 6, 
ZT 12, ZT 16, and ZT 22 between control and 50M NMDA-treated slices, with the most amount of NMDA-
induced cell death occurring at ZT 6 (n = 3). 
3.3 Degree of cell death in the SCN is independent of NMDA concentration 
The degree of cell damage or death in the SCN resulting from in vitro NMDA treatment 






















































































































































previous studies [4, 13]. The results of our dose-response experiments are displayed, showing 
that EBSS alone or EBSS containing 50M, 100M, and 500M NMDA-bath applications at ZT 
6 to brain slices prepared from a mouse induced minimal cell death, with no significant 
differences between each dosage as evidenced by constant percentage values for Grade 1, Grade 
2, and Grade 3 cells across each treatment (Figure 12). 
 
Fig. 12. Constant percentage of cell death relative to total number of cells in the SCN after 1 hour of exposure to 
increasing doses of NMDA from 0M (control) to 50M, 100M, and 500M (n = 3). 
4. Discussion 
Through these experiments, we have demonstrated that the SCN displays a unique 
endogenous resilience to NMDA-induced excitotoxicity that persists across time and with 
increasing concentrations of NMDA, rendering it more protected against overexcitation 
compared to other brain regions; however, the mechanism through which this occurs is still 
unknown. Understanding how the SCN resists excitoxic shock has various clinical implications 
that could potentially lead to advancements in ischemic stroke and neurodegenerative disease 
treatments as well as various other neurological disorders that disrupt circadian rhythms. 
Limitations for this study include the insufficient number of samples available in order to run 





or death (PI staining), ImageJ analyses performed by multiple researchers, employing only one 
type of stressor (NMDA-induced excitotoxicity) where other methods might result in regional 
differences in resilience or susceptibility, and that these results are purely observational and thus 
do not provide functional information about the SCN or other brain regions. Further studies 
addressing this underlying mechanism behind the SCN’s defense system could allow researchers 
and health care professionals to directly reproduce the cell machinery of this mechanism where 
the stroke took place in order to repair the damage or even prevent future events by treating at-
risk patients before a stroke occurs. 
However, more work is needed to further support our results and allow for future medical 
innovation. Such steps include increasing the number of samples to conduct an ANOVA test to 
more clearly define the relationship between the SCN and the other brain regions, and testing 
higher concentrations of NMDA to determine whether the SCN exhibits a response to 
excitotoxic stimuli using a more robust stressor. Additionally, since both AMPA and NMDA 
receptors are associated with the excitoxic response, we want to investigate whether AMPA 
induces the same effects—or lack thereof—on SCN tissue or whether it leads to the same levels 
of NMDA-induced cell damage and death in other brain regions. Then, to determine whether the 
SCN only displays resilience to excitoxicity or various types of cell death (i.e., metabolic or 
mitochondrial breakdown), we want to test SCN resilience under oxygen-glucose deprivation 
compared to that of other brain regions. We also want to use MTT and LDH assays to look at the 
SCN’s excitotoxic response alone compared to that of other brain areas, which would indicate 
the level of cell viability by highlighting the presence of mitochondrial dysfunction characteristic 
of cell death. Since succinate dehydrogenase is a mitochondrial resident protein, the MTT assay 





present in the cytoplasm and thus converts MTT into MTT-formazan, then the mitochondrial 
membrane is no longer intact. Similarly, since LDH is also a resident mitochondrial protein, the 
LDH assay would allow for fluorescent visualization of pyruvate formed from cytoplasmic 
lactate if the mitochondrial membrane is broken down. 
If these additional experiments also indicate an endogenous resilience unique to the SCN, 
then future studies should investigate the specific cellular mechanism(s) that give rise to this 
protective quality. One potential area of study involves intracellular calcium ion (Ca2+) 
concentration following NMDA receptor activation in the SCN versus other brain regions. One 
possibility is that the SCN expresses a unique NMDA receptor subunit composition, which might 
restrict Ca2+ inflow into SCN cells relative to those in other brain areas and prohibit the 
excessive overstimulation implicated in cell damage and death. Additionally, microglia are 
known to play both neuroprotective and neurodegenerative functions in brain cells. Because of 
this these contradictory actions, the specific role of microglia in SCN resiliency should be 
investigated by comparing SCN microglia morphology and functional status post excitotoxic 
stimulus relative to that of other brain regions. This would determine whether the SCN’s 
increased resilience to excitoxicity could be attributed to the presence of less reactive microglia 
that are more ramified—the typical physiological state of a healthy, resting central nervous 
system—and release fewer pro-inflammatory substances when the cell is overstimulated, 
whereas microglia in different brain regions would be more reactive and less ramified—a state of 
hypertrophy caused by acute injury. 
In conclusion, excitotoxic stimuli induce a lesser effect on the SCN compared to other 
brain regions. The aforementioned experiments indicate that the SCN exhibits the least amount 





may be attributed to differential intracellular Ca2+ concentration due to unique NMDA receptor 
composition or microglia morphology and reactivity specific to SCN cells, it will be important to 
understand the exact endogenous mechanism through which the SCN is better protected against 
NMDA-induced cell damage and death. These results suggest that somehow, SCN cells employ 
a unique defense mechanism at the onset of excitotoxic stimuli that render them more able to 
resist its deleterious effects. Understanding the specific cell machinery behind this phenomenon 
can help us determine the SCN’s role in neurological recovery after an event such as an ischemic 
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